Dachaigh › Melanoma › Utah › Salt Lake City
Sgrùdaidhean clionaigeach Melanoma ann an Salt Lake City, UT
Tha 21 sgrùdaidhean airson Melanoma a’ lorg phàirtichean aig làraichean ann agus timcheall air Salt Lake City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma
A’ fastadhÌre 2
- Huntsman Cancer Institute, Salt Lake City
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A’ fastadhÌre 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
A’ fastadhÌre 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
A’ fastadhÌre 3
- Intermountain Health, Salt Lake City
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
A’ fastadhÌre 2
- Primary Children's Hospital, Salt Lake City
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
A’ fastadhÌre 1/2
- University of Utah - Huntsman Cancer Institute, Salt Lake City
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
A’ fastadhÌre 2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
A’ fastadhSgrùdadh amharc
- Utah Cancer Specialists, Salt Lake City
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
A’ fastadhÌre 1/2
- Huntsman Cancer Institute/University of Utah, Salt Lake City
Project: Every Child for Younger Patients With Cancer
A’ fastadhSgrùdadh amharc
- Primary Children's Hospital, Salt Lake City
Rural Adult and Youth Sun Protection Study
A’ fastadhFàilte do shaor-thoilich fhallain
- University of Utah, Salt Lake City
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
A’ fastadhÌre 1/2
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
A’ fastadh
- Huntsman Cancer Institute at The University of Utah, Salt Lake City
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
A’ fastadhÌre 1/2
- Huntsman Cancer Institute, Salt Lake City
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
A’ fastadh
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
A’ fastadhÌre 3
- University of Utah Huntsman Cancer Institute, Salt Lake City
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
A’ fastadhÌre 3
- Huntsman Cancer Institute, University of Utah 2000 Circle of Hope, Salt Lake City, UT
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma
A’ fastadhÌre 1/2
- Huntsman Cancer Institute, Salt Lake City
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
A’ fastadhÌre 1/2
- Huntsman Cancer Institute - University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A’ fastadhSgrùdadh amharc
- Massive Bio SYNERGY-AI site, Salt Lake City
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
A’ fastadh
- Huntsman Cancer Institute (The University of Utah), Salt Lake City
Sgrùdaidhean Melanoma ann am bailtean eile
- Houston, TX59 sgrùdaidhean
- New York City, NY38 sgrùdaidhean
- Los Angeles, CA34 sgrùdaidhean
- Nashville, TN33 sgrùdaidhean
- Pittsburgh, PA31 sgrùdaidhean
- Boston, MA26 sgrùdaidhean
- Philadelphia, PA23 sgrùdaidhean
- San Francisco, CA22 sgrùdaidhean
- Columbus, OH21 sgrùdaidhean
- Durham, NC21 sgrùdaidhean
- Atlanta, GA21 sgrùdaidhean
- St. Louis, MO21 sgrùdaidhean
Sgrùdaidhean eile ann an Salt Lake City
- Aillse Sgamhain Neo-chealla-beag31 sgrùdaidhean
- Aillse (gach seòrsa)27 sgrùdaidhean
- Aillse a' bhroilleach27 sgrùdaidhean
- Aillse colorectal22 sgrùdaidhean
- Ailseachadh nan Sgamhan21 sgrùdaidhean
- Myeloma iomaill21 sgrùdaidhean
- Ailse metastatach20 sgrùdaidhean
- Cancer Ovarian19 sgrùdaidhean
- Obesity18 sgrùdaidhean
- Leukemia myeloid geur17 sgrùdaidhean
- Fàilligeadh a' Chridhe17 sgrùdaidhean
- Aillse Prostata15 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.